Norbert Stute

Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use

Norbert Stute, Katja Holtz, Michaël Bubenheim et al. · Experimental Hematology · 2004 · 271 citations · Full text

Life Sciences, Biomedical Engineering, Cell Biology +15

Pilot study of reduced‐intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis

Nicolaus Kröger, Tatjana Zabelina, Heike Schieder et al. · British Journal of Haematology · 2005 · 126 citations · Full text

Medicine, Hematology, Immunology +15

Pharmacokinetics of subcutaneous recombinant human granulocyte colony- stimulating factor in children

Norbert Stute, VM Santana, JH Rodman et al. · Blood · 1992 · 88 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +6

Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy.

Wayne L. Furman, Diane L. Fairclough, Richard D. Huhn et al. · Journal of Clinical Oncology · 1991 · 83 citations

Medicine, Pharmacokinetics, Pharmacology +16

Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment‐related mortality in stem cell transplantation from unrelated donors using pretransplant<i>in vivo</i>T‐cell depletion with anti‐thymocyte globulin

Nicolaus Kröger, Tatjana Zabelina, William Krüger et al. · British Journal of Haematology · 2001 · 79 citations · Full text

Medicine, Immunology, Infectious Diseases +17